Key facts
- It has raised $5.9M; the latest was Early Stage VC ($5.9M) in Aug 2025.
- Notable investors include Nordic Mentor Network For Entrepreneurship, T&W Medical.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Optheras
- ·The full record, as it builds
Funding rounds
No funding rounds for Optheras are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Optheras
Developer of laser technology designed to perform photothermal coagulation for targeting and treating non-invasive bladder tumors. The company offers office-based treatment that avoids the need for an operating room, enabling urologists to care for Ta low-grade bladder cancer patients with less pain and reduced invasiveness.
- Sector
- Healthcare
- HQ
- Birkerod, Denmark
- Founded
- 2022
- Employees
- 22
- Website
- optheras.com/
- Ownership
- Privately Held (backing)
Optheras doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Optheras shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Optheras in its N-PORT filings yet. We sweep new filings monthly.